Skip to main content
Figure 4 | BMC Bioinformatics

Figure 4

From: A strategy to build and validate a prognostic biomarker model based on RT-qPCR gene expression and clinical covariates

Figure 4

The Lasso_Cox −4 model offers the best compromise between performance and validation surprise. Panel A presents the cross-validated time-dependent AUC for the 4 candidate models using strategy B (PCR batch level sampling). Panel B the cross-validated using strategy B time-dependent “validation surprise” computed from the AUC for the 4 candidate models.

Back to article page